Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 32% ± 12% | |
peripheral blood | 10 studies | 23% ± 7% | |
intestine | 10 studies | 28% ± 10% | |
liver | 6 studies | 23% ± 6% | |
kidney | 5 studies | 24% ± 6% | |
brain | 5 studies | 24% ± 5% | |
placenta | 4 studies | 33% ± 12% | |
uterus | 4 studies | 40% ± 14% | |
prostate | 4 studies | 31% ± 11% | |
breast | 4 studies | 31% ± 6% | |
bone marrow | 3 studies | 17% ± 1% | |
eye | 3 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2345.03 | 1445 / 1445 | 100% | 40.65 | 183 / 183 |
liver | 100% | 2432.81 | 226 / 226 | 100% | 48.27 | 406 / 406 |
pancreas | 100% | 2969.45 | 328 / 328 | 100% | 64.42 | 178 / 178 |
prostate | 100% | 2789.02 | 245 / 245 | 100% | 76.05 | 502 / 502 |
skin | 100% | 2812.88 | 1809 / 1809 | 100% | 63.66 | 472 / 472 |
stomach | 100% | 2502.94 | 359 / 359 | 100% | 50.95 | 286 / 286 |
thymus | 100% | 2784.14 | 653 / 653 | 100% | 48.57 | 604 / 605 |
lung | 100% | 3335.99 | 577 / 578 | 100% | 61.01 | 1155 / 1155 |
intestine | 100% | 3033.49 | 966 / 966 | 100% | 61.57 | 526 / 527 |
uterus | 100% | 2186.56 | 170 / 170 | 100% | 55.67 | 458 / 459 |
kidney | 100% | 2338.94 | 89 / 89 | 100% | 39.90 | 899 / 901 |
breast | 100% | 2979.57 | 459 / 459 | 100% | 63.90 | 1114 / 1118 |
ovary | 100% | 2117.33 | 180 / 180 | 100% | 33.58 | 428 / 430 |
bladder | 100% | 2605.67 | 21 / 21 | 99% | 56.52 | 501 / 504 |
adrenal gland | 100% | 3797.22 | 258 / 258 | 99% | 75.26 | 228 / 230 |
brain | 98% | 1262.67 | 2595 / 2642 | 100% | 44.08 | 705 / 705 |
adipose | 100% | 3209.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3371.39 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 48.45 | 29 / 29 |
spleen | 100% | 3133.70 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.98 | 1 / 1 |
muscle | 100% | 2126.77 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 2109.55 | 853 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 25.86 | 72 / 80 |
peripheral blood | 67% | 922.88 | 622 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045454 | Biological process | cell redox homeostasis |
GO_0030970 | Biological process | retrograde protein transport, ER to cytosol |
GO_0098869 | Biological process | cellular oxidant detoxification |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_2000110 | Biological process | negative regulation of macrophage apoptotic process |
GO_1902236 | Biological process | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway |
GO_0009749 | Biological process | response to glucose |
GO_0032715 | Biological process | negative regulation of interleukin-6 production |
GO_0080164 | Biological process | regulation of nitric oxide metabolic process |
GO_0045184 | Biological process | establishment of protein localization |
GO_0006983 | Biological process | ER overload response |
GO_0051771 | Biological process | negative regulation of nitric-oxide synthase biosynthetic process |
GO_0006111 | Biological process | regulation of gluconeogenesis |
GO_0030968 | Biological process | endoplasmic reticulum unfolded protein response |
GO_0002865 | Biological process | negative regulation of acute inflammatory response to antigenic stimulus |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0051775 | Biological process | response to redox state |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0045719 | Biological process | negative regulation of glycogen biosynthetic process |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0036503 | Biological process | ERAD pathway |
GO_0046325 | Biological process | negative regulation of glucose import |
GO_0005886 | Cellular component | plasma membrane |
GO_0036502 | Cellular component | Derlin-1-VIMP complex |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0034362 | Cellular component | low-density lipoprotein particle |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005881 | Cellular component | cytoplasmic microtubule |
GO_0034361 | Cellular component | very-low-density lipoprotein particle |
GO_0036513 | Cellular component | Derlin-1 retrotranslocation complex |
GO_0019899 | Molecular function | enzyme binding |
GO_1990381 | Molecular function | ubiquitin-specific protease binding |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0016209 | Molecular function | antioxidant activity |
GO_0051117 | Molecular function | ATPase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SELENOS |
Protein name | Selenoprotein S (SelS) (VCP-interacting membrane protein) Selenoprotein S |
Synonyms | SELS VIMP SBBI8 AD-015 |
Description | FUNCTION: Involved in the degradation process of misfolded endoplasmic reticulum (ER) luminal proteins. Participates in the transfer of misfolded proteins from the ER to the cytosol, where they are destroyed by the proteasome in a ubiquitin-dependent manner. Probably acts by serving as a linker between DERL1, which mediates the retrotranslocation of misfolded proteins into the cytosol, and the ATPase complex VCP, which mediates the translocation and ubiquitination. . FUNCTION: Involved in the degradation process of misfolded endoplasmic reticulum (ER) luminal proteins. Participates in the transfer of misfolded proteins from the ER to the cytosol, where they are destroyed by the proteasome in a ubiquitin-dependent manner. Probably acts by serving as a linker between DERL1, which mediates the retrotranslocation of misfolded proteins into the cytosol, and the ATPase complex VCP, which mediates the translocation and ubiquitination. . FUNCTION: Involved in the degradation process of misfolded endoplasmic reticulum (ER) luminal proteins. Participates in the transfer of misfolded proteins from the ER to the cytosol, where they are destroyed by the proteasome in a ubiquitin-dependent manner. Probably acts by serving as a linker between DERL1, which mediates the retrotranslocation of misfolded proteins into the cytosol, and the ATPase complex VCP, which mediates the translocation and ubiquitination. . |
Accessions | ENST00000398226.7 ENST00000531964.5 E9PN30 ENST00000528346.1 ENST00000526049.6 Q9BQE4 A0A182DWI4 |